Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacia Turns to Genaissance for Pharmacogenomics

NEW YORK, Dec. 17-Genaissance will supply pharmacogenomics services for Pharmacia, the company said today.


Through this agreement, Genaissance will use its HAP technology to probe the genetics of drug response for compounds in clinical trials at Pharmacia.


Genaissance already has pharmacogenomic partnerships with AstraZeneca, Johnson & Johnson and Pfizer.


Financial details of the relationship were not disclosed, although Genaissance says that partnerships based on its HAP technology generally swap haplotype data access and services for a package that includes licensing fees, service fees, milestone payments and royalties.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.